Lexicon Pharmaceuticals
LXRX
#7142
Rank
A$0.76 B
Marketcap
A$2.11
Share price
-1.41%
Change (1 day)
109.15%
Change (1 year)

Lexicon Pharmaceuticals (LXRX) - Cash on Hand

Cash on Hand as of September 2025 : A$0.17 Billion

According to Lexicon Pharmaceuticals 's latest financial reports the company has A$0.17 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Lexicon Pharmaceuticals - Cash on Hand chart (from 2000 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31A$0.38 B53.3%
2023-12-31A$0.24 B22.75%
2022-12-31A$0.20 B69.93%
2021-12-31A$0.11 B-39.58%
2020-12-31A$0.19 B-48.96%
2019-12-31A$0.38 B70.78%
2018-12-31A$0.22 B-42.93%
2017-12-31A$0.39 B-17.19%
2016-12-31A$0.48 B-32.83%
2015-12-31A$0.71 B72.6%
2014-12-31A$0.41 B186.42%
2013-12-31A$0.14 B-32.6%
2012-12-31A$0.21 B-21.82%
2011-12-31A$0.27 B32.19%
2010-12-31A$0.20 B14.88%
2009-12-31A$0.18 B23.78%
2008-12-31A$0.14 B-50.62%
2007-12-31A$0.29 B191.66%
2006-12-31A$0.10 B-25.52%
2005-12-31A$0.13 B20.42%
2004-12-31A$0.11 B-19.16%
2003-12-31A$0.13 B-15.76%
2002-12-31A$0.16 B-43.38%
2001-12-31A$0.29 B-19.06%
2000-12-31A$0.36 B2501.37%
1999-12-31A$13.93 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Eterna Therapeutics
ERNA
A$4.58 M-97.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
A$12.71 B 7,182.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
A$0.64 B 266.75%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
A$2.22 B 1,174.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
A$5.33 B 2,958.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
A$0.13 B-20.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
A$1.92 B 1,002.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
A$1.01 B 483.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
A$0.25 B 48.74%๐Ÿ‡บ๐Ÿ‡ธ USA